U.S. health body questions robustness of AstraZeneca's COVID-19 vaccine trial data
Reuters #1 - 9 months ago
Reuters #1 - 9 months agoBiden: U.S. exploring monkeypox vaccines; ‘everybody’ should be concerned
Washington Post #3 - 3 years ago
Washington Post #3 - 3 years agoCovid Live Updates: Global Caseload Surpasses 400 Million
New York Times #1 - 2 months ago
New York Times #1 - 2 months agoWhy manufacturers are hiking COVID vaccine prices
PBS NewsHour #2 - 4 weeks ago
PBS NewsHour #2 - 4 weeks agoU.S. readies vaccine rollout with deaths rising by 3,000 per day
Reuters #1 - 12 months ago
Reuters #1 - 12 months agoEXPLAINER: Are we going to need COVID-19 booster shots?
Associated Press #1 - 2 months ago
Associated Press #1 - 2 months agoCovid-19 Live Updates: Vaccine Supplies Falling Short as States Expand Access
New York Times #1 - 12 months ago
New York Times #1 - 12 months agoBritain begins Pfizer vaccine shots, launching the West’s first mass coronavirus inoculation effort
Washington Post #1 - 4 years ago
Washington Post #1 - 4 years agoWhat to Know About New B.1.1.529 Variant of COVID-19
Time #1 - 2 months ago
Time #1 - 2 months agoEU and UK regulators still recommend AstraZeneca shot despite possible link to blood clots
Reuters #1 - 3 months ago
Reuters #1 - 3 months agoCovid on the Run
New York Times #1 - 13 months ago
New York Times #1 - 13 months agoCovid 19 live updates E.U. medical official urges caution over some states’ preliminary approval of Russia’s Sputnik V
Washington Post #1 - 4 years ago
Washington Post #1 - 4 years agoUS Dictates Foreign Policy to Australia But Won’t Give It Excess Vaccines
Consortium News #1 - 9 hours ago
Consortium News #1 - 9 hours agoOxford-AstraZeneca Vaccine Approval May Be the Most Globally Important Yet
Time #1 - 7 months ago
Time #1 - 7 months agoCovid Live Updates: U.S. Lifts Travel Ban for Vaccinated Foreigners
New York Times #1 - 7 months ago
New York Times #1 - 7 months agoMask mandates continue to fall as Fauci says U.S. may be approaching ‘normality’
Washington Post #1 - 3 years ago
Washington Post #1 - 3 years agoAshish Jha on the case for vaccine certificates to beat covid-19
Economist #1 - 11 months ago
Economist #1 - 11 months agoUS to double COVID-19 vaccine purchases for global distribution
Al Jazeera #1 - 2 months ago
Al Jazeera #1 - 2 months agoJohnson & Johnson, Hong Kong, Sheet Pan Dinners: Your Wednesday Evening Briefing
New York Times #1 - 4 years ago
New York Times #1 - 4 years agoFDA advisers recommend Pfizer-BioNTech coronavirus vaccine, with agency action expected soon
Washington Post #1 - 5 years ago
Washington Post #1 - 5 years agoOmicron looks ominous. How bad is it likely to be?
Economist #1 - 4 weeks ago
Economist #1 - 4 weeks agoCOVID-19: Who to Blame for the Latest Crisis
Consortium News #1 - 10 days ago
Consortium News #1 - 10 days agoCovid Live Updates: China Pledges 1 Billion Vaccine Doses for Africa
New York Times #1 - 7 months ago
New York Times #1 - 7 months agoMore than 4 in 10 health-care workers have not been vaccinated, Post-KFF poll finds
Washington Post #1 - 4 years ago
Washington Post #1 - 4 years agoUS bets on untested company to deliver COVID-19 vaccine
Associated Press #1 - 2 years ago
Associated Press #1 - 2 years agoCOVID-19: Vaccine Just out of Reach for Palestinians
Consortium News #1 - 3 months ago
Consortium News #1 - 3 months agoCovid Live Updates: New York City Schools Reopen With Hope, and Anxiety
New York Times #1 - 2 years ago
New York Times #1 - 2 years agoModerna to ask the FDA to greenlight its coronavirus vaccine
Washington Post #1 - 4 years ago
Washington Post #1 - 4 years agoVaccine mandates are spreading
Economist #1 - 2 months ago
Economist #1 - 2 months agoWho Gets it First?
Consortium News #1 - 7 months ago
Consortium News #1 - 7 months agoCovid Live Updates: Delta Variant Drives New Lockdowns in Asia and Australia
New York Times #1 - 2 years ago
New York Times #1 - 2 years agoSingle-shot Johnson & Johnson vaccine 66 percent effective against moderate and severe illness
Washington Post #1 - 4 years ago
Washington Post #1 - 4 years agoCoronavirus: Are we getting closer to a vaccine or drug?
BBC News #1 - 2 years ago
BBC News #1 - 2 years agoCOVAX Isn’t Africa’s Silver Bullet
Consortium News #1 - 17 hours ago
Consortium News #1 - 17 hours agoCovid Live Updates: mRNA Vaccines May Offer Lasting Protection, Study Finds
New York Times #1 - 15 months ago
New York Times #1 - 15 months agoEuropean Union begins coronavirus vaccine rollout amid concerns over supply
Washington Post #1 - 4 years ago
Washington Post #1 - 4 years agoAnother shot in the foot - How Europe’s vaccine caution can cost lives
Economist #1 - 2 years ago
Economist #1 - 2 years agoFull transcript: Dr. Anthony Fauci on "Face the Nation," Nov. 27, 2022
CBS #2 - 7 months ago
CBS #2 - 7 months agoShould You Get a Measles Booster Shot? Here’s What Experts Say
Time #1 - 6 years ago
Time #1 - 6 years agoThese are the top coronavirus vaccines to watch
Washington Post #1 - 4 years ago
Washington Post #1 - 4 years ago
